These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25764781)

  • 1. [Radioiodine--today's trends in treatment of benign thyroid diseases].
    Łabuzek K; Kukla U; Chronowska J; Madej P; Okopień Bogusław
    Wiad Lek; 2014; 67(2 Pt 1):80-4. PubMed ID: 25764781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.
    Bonnema SJ; Hegedüs L
    Endocr Rev; 2012 Dec; 33(6):920-80. PubMed ID: 22961916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
    Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of radioiodine therapy on urinary iodine excretion.
    Meller B; Lauer I; Bähre M; Richter E
    Nuklearmedizin; 1998 May; 37(3):107-12. PubMed ID: 9604231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine treatment for benign thyroid diseases.
    Weetman AP
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):757-64. PubMed ID: 17466000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
    Mattsson S; Johansson L; Jönsson H; Nosslin B
    Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases.
    Happel C; Kranert WT; Ackermann H; Binse I; Bockisch B; Gröner D; Herrmann K; Grünwald F
    Endocrine; 2019 Mar; 63(3):537-544. PubMed ID: 30599051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of toxicological hazards from medical radioiodine administration.
    Van Dyke M; Punja M; Hall MJ; Kazzi Z
    J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term parathyroid- and c-cell function after radioiodine for benign thyroid diseases.
    Mortensen LS; Smidt K; Jørgensen A; Nielsen JT; Laurberg P; Søndergaard L; Rungby J
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):22-8. PubMed ID: 15943755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of radioiodine treatment on the diseased thyroid gland.
    Riley AS; McKenzie GAG; Green V; Schettino G; England RJA; Greenman J
    Int J Radiat Biol; 2019 Dec; 95(12):1718-1727. PubMed ID: 31486712
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders.
    Pauwels EK; Thomson WH; Blokland JA; Schmidt ME; Bourguignon M; El-Maghraby TA; Broerse JJ; Harding LK
    Eur J Nucl Med; 1999 Nov; 26(11):1453-7. PubMed ID: 10552087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the absorbed dose to the common carotid arteries following radioiodine treatment of benign thyroid disease.
    la Cour JL; Hedemann-Jensen P; Søgaard-Hansen J; Nygaard B; Jensen LT
    Ann Nucl Med; 2013 Nov; 27(9):862-6. PubMed ID: 23881601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine for the treatment of thyroid disease.
    Drug Ther Bull; 1993 May; 31(10):39-40. PubMed ID: 8344135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radioiodine therapy of benign thyroid disease in Denmark].
    Rasmussen AK; Jarløv AE; Faber J
    Ugeskr Laeger; 2000 Jan; 162(3):327-30. PubMed ID: 10680467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis.
    Hieu TT; Russell AW; Cuneo R; Clark J; Kron T; Hall P; Doi SA
    Endocr Relat Cancer; 2012 Oct; 19(5):645-55. PubMed ID: 22851687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of factors influencing radioiodine (
    Topić Vučenović V; Rajkovača Z; Jelić D; Stanimirović D; Vuleta G; Miljković B; Vučićević K
    Eur J Clin Pharmacol; 2018 Aug; 74(8):1037-1045. PubMed ID: 29754217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine imaging and treatment in thyroid disorders.
    Griggs WS; Divgi C
    Neuroimaging Clin N Am; 2008 Aug; 18(3):505-15, viii. PubMed ID: 18656031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.